Bruker Corporation (BRKR)
 NASDAQ: BRKR · Real-Time Price · USD
 38.18
 +1.78 (4.89%)
  Oct 31, 2025, 10:39 AM EDT - Market open
 
 Revenue by Geography
 Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 
|---|
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 
|---|
|  | 940.30M | 938.50M |  |  |  |  | 
|  | 280.60M | 310.70M |  |  |  |  | 
|  | 940.10M | 873.00M |  |  |  |  | 
|  | 451.00M | 471.20M |  |  |  |  | 
| Rest of Asia Pacific Revenue | 564.10M | 518.50M |  |  |  |  | 
| Total Asia Pacific Revenue | 1.02B | 989.70M |  |  |  |  | 
|  | 266.70M | 254.50M |  |  |  |  | 
|  | 3.44B | 3.37B |  |  |  |  | 
Revenue
 Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 
|---|
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 
|---|
|  | 908.50M | 905.70M |  |  |  |  | 
|  | 1.17B | 1.09B |  |  |  |  | 
|  | 2.07B | 2.00B |  |  |  |  | 
|  | 1.11B | 1.10B |  |  |  |  | 
|  | 3.19B | 3.10B |  |  |  |  | 
|  | 266.40M | 283.00M |  |  |  |  | 
| Eliminations from Revenue | -12.10M | -14.10M |  |  |  |  | 
|  | -3.19B | -3.10B |  |  |  |  | 
|  | 3.44B | 3.37B |  |  |  |  | 
EBIT
 Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 
|---|
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 
|---|
| BSI BioSpin Operating Income | 131.10M | 157.80M |  |  |  |  | 
| BSI CALID Operating Income | 169.80M | 180.00M |  |  |  |  | 
| BSI Life Science Operating Income | 300.90M | 337.80M |  |  |  |  | 
| BSI Nano Operating Income | -25.30M | 2.30M |  |  |  |  | 
| Corporate, Eliminations and Other Operating Income | -122.10M | -121.90M |  |  |  |  | 
| Total BSI Operating Income | 153.45M | 218.20M |  |  |  |  | 
|  | 30.40M | 34.90M |  |  |  |  | 
|  | -153.45M | -218.20M |  |  |  |  | 
|  | 183.90M | 253.10M |  |  |  |  | 
Capital Expenditures
 Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 
|---|
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 
|---|
| BSI BioSpin Capital Expenditures | - | 22.80M |  |  |  |  | 
| BSI CALID Capital Expenditures | - | 34.10M |  |  |  |  | 
| BSI Life Science Capital Expenditures | - | 56.90M |  |  |  |  | 
| BSI Nano Capital Expenditures | - | 19.30M |  |  |  |  | 
| Corporate Capital Expenditures | - | 14.80M |  |  |  |  | 
| Total BSI Capital Expenditures | - | 91.00M |  |  |  |  | 
| BEST Capital Expenditures | - | 24.30M |  |  |  |  | 
Updated Aug 4, 2025. Data Source: 
Fiscal.ai.